Latest Shareholder Impact News

Identitii Limited has reopened its pro rata rights issue following a Takeovers Panel ruling, granting shareholders withdrawal rights and terminating the underwriting agreement.

Marimaca Copper has successfully raised C$409 million through a dual Canadian and Australian equity offering, positioning the company to advance its flagship Marimaca Project and exploration at Pampa Medina.

BKI Investment Company has finalised its on-market share purchases to satisfy its Dividend Reinvestment Plan obligations, setting the DRP price at $1.74 ahead of the 2026 interim dividend payment.

Regal Asian Investments Limited (ASX, RG8) has updated its Dividend Reinvestment Plan, eliminating the minimum participation requirement and streamlining administrative processes for shareholders.

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

Neuren Pharmaceuticals has initiated a discretionary on-market share buy-back program of up to 5%, citing a strong cash position and undervaluation relative to internal and analyst assessments.

BKI Investment Company has appointed Morgans Financial to conduct on-market share purchases to fulfill its Dividend Reinvestment Plan obligations, aiming to avoid dilution by pricing shares at no discount.

Cosmo Metals Limited has announced a fully underwritten entitlement offer to raise approximately $1.55 million, aimed at advancing drilling and exploration across its key gold and base metals projects. The offer includes new shares and attaching options, with funds earmarked for multiple projects in Western Australia and New South Wales.

CSL Limited has announced an ordinary dividend of USD 1.30 per share for the six months ending December 2025, payable in April 2026 with multi-currency options for shareholders.

Carnarvon Energy has announced the recommencement of its on-market share buy-back program, targeting up to 10% of its issued capital over the next year, funded from a healthy cash reserve.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

Aura Energy has successfully raised A$20 million through a heavily oversubscribed placement, aiming to accelerate development at its Tiris Uranium Project amid rising global uranium demand.